MY169848A - An antiviral composition for inhibiting dengue virus - Google Patents

An antiviral composition for inhibiting dengue virus

Info

Publication number
MY169848A
MY169848A MYPI2012000714A MYPI2012000714A MY169848A MY 169848 A MY169848 A MY 169848A MY PI2012000714 A MYPI2012000714 A MY PI2012000714A MY PI2012000714 A MYPI2012000714 A MY PI2012000714A MY 169848 A MY169848 A MY 169848A
Authority
MY
Malaysia
Prior art keywords
phyllanthus
dengue virus
antiviral composition
inhibiting dengue
extract
Prior art date
Application number
MYPI2012000714A
Inventor
Bala Jaganath Indu
Devi Sekaran Shamala
Original Assignee
Inst Penyelidikan Dan Kemajuan Pertanian Malaysia Mardi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Penyelidikan Dan Kemajuan Pertanian Malaysia Mardi filed Critical Inst Penyelidikan Dan Kemajuan Pertanian Malaysia Mardi
Priority to MYPI2012000714A priority Critical patent/MY169848A/en
Publication of MY169848A publication Critical patent/MY169848A/en

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an antiviral composition for inhibiting dengue virus. The composition comprises of an affective amount of Phyllanthus extract. Wherein the Phyllanthus extract comprises an active ingredient. Preferably, the Phyllanthus extract is selected from one or combination of Phyllanthus watsonii, Phyllanthus urinaria, Phyllanthus amarus and Phyllanthus niruri.
MYPI2012000714A 2012-02-17 2012-02-17 An antiviral composition for inhibiting dengue virus MY169848A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2012000714A MY169848A (en) 2012-02-17 2012-02-17 An antiviral composition for inhibiting dengue virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2012000714A MY169848A (en) 2012-02-17 2012-02-17 An antiviral composition for inhibiting dengue virus

Publications (1)

Publication Number Publication Date
MY169848A true MY169848A (en) 2019-05-17

Family

ID=79170322

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2012000714A MY169848A (en) 2012-02-17 2012-02-17 An antiviral composition for inhibiting dengue virus

Country Status (1)

Country Link
MY (1) MY169848A (en)

Similar Documents

Publication Publication Date Title
WO2015085318A3 (en) Targeted adaptive vaccines
MX2017013562A (en) Microbiome regulators and related uses thereof.
WO2014062720A3 (en) Methods of treating cancer
PH12016501122A1 (en) Delayed release compositions of linaclotide
CR20140421A (en) PESTICIDE CEPA OF FLAVOBACTERIUM AND BIOACTIVE COMPOSITIONS, METABOLITES AND USES OF THE SAME
BR112014021531A8 (en) compound, pharmaceutical composition and uses thereof
MX2016008448A (en) Var2csa-drug conjugates.
WO2014062733A3 (en) Substituted benzene compounds
EA201492002A1 (en) ANTI-VIRUS COMPOUNDS
EA024842B9 (en) Compounds as modulators of pi3k protein kinase
PH12015502588A1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
PH12016501724A1 (en) Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
EA201992707A1 (en) COMPOUNDS AND THEIR APPLICATIONS FOR HEMOGLOBIN MODULATION
EA201101214A1 (en) POLYENE COMBINATION COMPOSITIONS
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
EP2931310A4 (en) Compositions, methods of administration and uses for trivalent dengue virus formulations
WO2015095735A3 (en) Vaccine compositions and uses thereof
SG11201504701UA (en) Immunogenic composition comprising elements of c. difficile cdtb and/or cdta proteins
WO2014100351A3 (en) 8'-hydroxy-dihydroergotamine compounds and compositions
PL2654762T3 (en) Extract of the aerial parts of gynandropsis gynandra and cosmetic, dermatoligic and pharmaceutic compositions comprising the extract
PH12015501099A1 (en) Synbiotic composition and use thereof
EP3071214A4 (en) Salacia compositions, methods of treatment by their administration, and methods of their preparation
IL224029A (en) Triazines and pyrimidines , compositions comprising same and use thereof for the treatment of insects
MX2014002068A (en) Co-crystals of cyprodinil and dithianon.
MX2015001648A (en) Compositions comprising spicamycin derivatives and methods of use thereof.